Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
GLP-1 medications bind to GLP-1 receptors in the brain, particularly in areas controlling appetite and satiety, which leads to reduced hunger and increased feelings of fullness after eating
Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk
Its pathway to NHS availability will depend on the successful completion of Phase 3 TRIUMPH trials, followed by a marketing authorisation application to the MHRA (the UK's independent medicines regulator) and potentially the EMA for European markets
30G or 31G
The patient's estimated copay is $0 if their prior authorization is approved, which is based on information from a representative at their insurer, Blue Cross Blue Shield, according to the report
US$ 29.35
US$ 28.89
US$ 24.59
US$ 23.99
US$ 24.98
US$ 28.64
US$ 26.09
US$ 27.15
